JNU-0921 is a potent and orally active CD137 agonist. JNU-0921 increases the mRNA expression of IFN-gamma and GZMB. JNU-0921 induces luciferase activity with an EC50 value of 64.07 nM.JNU-0921 enhances effector and memory function of cytotoxic CD8+ T cells (CTLs) and alleviates their exhaustion. JNU-0921 also skews polarization of helper T cells toward T helper 1 type and enhances their activity to boost CTL function. JNU-0921 shows anticancer activity[1].
Molekulargewicht:
316.31
Reinheit:
99.77
CAS Nummer:
[3079468-41-7]
Formel:
C19H12N2O3
Target-Kategorie:
TNF Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten